Anti-Polyserase-1 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the amino-terminal region of human Polyserase-1 (TMPRSS9), validated for Western blot applications.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Rat, Monkey
UniProt
Q7Z410
Size
100ug
Cat. #
RP1Polyserase1

In stock

SKU
RP-Polyserase1

Options

As low as: $130.00

Target Overview

Polyserase-1 (polyserine protease 1; also designated Transmembrane protease serine 9, TMPRSS9; UniProt Q7Z410) is a 1,059-residue type II transmembrane serine protease belonging to the TTSP family (EC 3.4.21.-). It is distinguished by an unusual multi-domain architecture containing three tandem serine protease domains within a single polypeptide, which are post-translationally processed into separate active subunits termed Serase-1, Serase-2, and Serase-3. The full-length protein is anchored at the cell membrane via its N-terminal transmembrane segment, with the catalytic domains projecting into the extracellular space. Serase-1 and Serase-2 are catalytically competent and hydrolyze the synthetic substrates N-t-Boc-Gln-Ala-Arg-AMC and N-t-Boc-Gln-Gly-Arg-AMC, consistent with trypsin-like specificity favoring cleavage after basic residues. N-t-Boc-Ala-Phe-Lys-AMC and N-t-Boc-Ala-Pro-Ala-AMC are not significantly processed, indicating selectivity beyond simple P1 preference. The third domain (Serase-3) lacks one or more catalytic triad residues and is presumed inactive. Polyserase-1 transcripts have been detected across multiple tissues, and the protein has drawn interest as a candidate effector in pericellular proteolysis and in the activation of other zymogens or cell-surface substrates. For investigators dissecting the contributions of individual catalytic domains, Triple Point Biologics offers five lots (RP1Polyserase1 through RP5Polyserase1) raised against the amino-terminal region, enabling detection of full-length protein and N-terminal cleavage products. Validated reactivity is against human; rat and monkey reactivity is predicted based on sequence conservation.

Background

Polyserase-1 was identified as a member of the type II transmembrane serine protease family, a group that includes matriptase, hepsin, and the TMPRSS subfamily, several of which have been implicated in epithelial homeostasis, viral envelope activation, and tumor progression. The unusual three-protease-domain organization of TMPRSS9 distinguishes it from most other TTSPs, which carry a single catalytic domain. Proteolytic processing releases Serase-1 and Serase-2 as catalytically active fragments, while membrane retention of the parent molecule positions catalytic activity at the cell surface, where it may participate in pericellular substrate cleavage. Genetic and animal-modeling studies have linked TMPRSS9 to several physiological and disease contexts. Chen et al (2020) combined whole exome sequencing with mouse modeling and proposed TMPRSS9 as a candidate gene for autism spectrum disorder, reporting behavioral phenotypes in knockout animals (PMID 31943016). A subsequent integrative transcriptome-wide association study identified TMPRSS9 among risk genes for bipolar disorder (Yang et al, 2024). More recently, Auberson et al (2025) used a combination of human genetic association data and animal modeling to nominate TMPRSS9 as a gene contributing to variation in serum potassium, suggesting a role in renal or systemic ion handling that has not previously been characterized. Outside of mammalian biology, related transmembrane serine proteases have been examined in the context of viral glycoprotein activation. Feng et al (2023) characterized embryonic chicken proteases — including TMPRSS family members — that activate Newcastle disease virus, and TMPRSS9 expression has been reported in laying hen magnum tissue in the context of egg-white protein synthesis (Sah et al, 2021). Collectively, the published record suggests Polyserase-1 functions in pericellular and luminal proteolysis with consequences for neurodevelopment, ion homeostasis, and reproductive tract biology. Mechanistic studies identifying the in vivo substrates of Serase-1 and Serase-2 remain an open area for investigation.

References

  1. Auberson M et al (2025) Combination of genetic studies and animal modeling proposes TMPRSS9 as a candidate gene for serum K(+) variations. Sci Rep. PubMed · DOI.
  2. Yang R et al (2024) Integrative analysis of transcriptome-wide association study and mRNA expression profile identified risk genes for bipolar disorder. Neurosci Lett. PubMed · DOI.
  3. Feng H et al (2023) Identification of Embryonic Chicken Proteases Activating Newcastle Disease Virus and Their Roles in the Pathogenicity of Virus Used as In Ovo Vaccine. J Virol. PubMed · DOI.
  4. Sah N et al (2021) RNA sequencing-based analysis of the magnum tissues revealed the novel genes and biological pathways involved in the egg-white formation in the laying hen. BMC Genomics. PubMed · DOI.
  5. Chen CA et al (2020) Combination of whole exome sequencing and animal modeling identifies TMPRSS9 as a candidate gene for autism spectrum disorder. Hum Mol Genet. PubMed · DOI.

Additional Specifications

Gene Symbol TMPRSS9
UniProt ID Q7Z410
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Rat, Monkey
Pack Size 100ug
Immunogen (Aminoterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-51.
Immunogen (Stem Region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 10-29.
Immunogen (Serase-1 domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 251-490.
Immunogen (Serase-2 domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 491-750.
Immunogen (Serase-3 domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 751-1059.
Alternate Names TMPRSS9, Transmembrane protease serine 9, Polyserase-I, Polyserine protease 1, Serase-1, Serase-2, Serase-3, EC 3.4.21.-

Frequently Asked Questions

What bands should I expect to see on Western blot with the Polyserase-1 antibody?

Polyserase-1 undergoes post-translational processing to generate three separate serine protease domains: Serase-1, Serase-2, and Serase-3. On Western blot, you may observe the full-length 1,059-residue precursor (approximately 116 kDa) along with processed fragments corresponding to individual Serase domains, typically in the 30-40 kDa range depending on glycosylation state. Band patterns vary by cell type and activation status. Using lysates from cells known to express TMPRSS9, such as certain epithelial lines, will help you distinguish specific signal from background. Always include a negative control lysate from a TMPRSS9-null cell line.

Does the Polyserase-1 antibody recognize all three Serase domains or just one?

The epitope mapping for this polyclonal antibody determines which processed forms it detects. Rabbit polyclonals raised against a broad region of Polyserase-1 often recognize epitopes present in one or more of the Serase domains, but cross-reactivity among Serase-1, -2, and -3 is not guaranteed because they share limited sequence identity despite functional similarity. If your experimental goal requires distinguishing individual Serase subunits, confirm epitope location with the datasheet or contact technical support. For general Polyserase-1 expression profiling, detection of any processed form typically suffices to demonstrate pathway activity.

What is the recommended starting dilution for Western blot with this antibody?

The validated dilution for Western blot is 1:1,000 in blocking buffer, typically 5% non-fat milk or BSA in TBST. This ratio has been optimized during validation with human lysates. However, Polyserase-1 expression varies widely by tissue and cell type; epithelial and certain tumor lines show higher expression. If initial signal is weak, titrate down to 1:500 or concentrate your lysate. Conversely, if background is high, extend blocking time or try 1:2,000. Overnight incubation at 4°C often improves sensitivity for low-abundance transmembrane proteases compared to one-hour room-temperature protocols.

Is this Polyserase-1 antibody validated for immunohistochemistry on paraffin sections?

Yes, Triple Point Biologics antibodies are validated for immunohistochemistry, including paraffin-embedded tissue. For Polyserase-1, antigen retrieval is typically required because formalin fixation masks epitopes on transmembrane proteins. Use citrate buffer (pH 6.0) or Tris-EDTA (pH 9.0) retrieval in a pressure cooker or steamer for 20 minutes. Given Polyserase-1 localization at the plasma membrane with extracellular catalytic domains, expect membranous and sometimes cytoplasmic staining in positive cells. Start with a 1:100 to 1:200 dilution and optimize on control tissue known to express TMPRSS9, such as normal colonic or prostate epithelium.

Will this antibody cross-react with rat or monkey Polyserase-1?

Rat and monkey cross-reactivity are listed as potential, meaning sequence homology predicts recognition but formal validation has not been completed. Human and rat TMPRSS9 share approximately 70-75% identity in conserved protease domain regions, so cross-reactivity is plausible but band patterns may differ. Monkey orthologs are typically more similar to human. If working with non-human species, run a pilot Western blot alongside a validated human lysate as positive control. Adjust dilution and exposure time as needed, and consider verifying hits by qPCR or mass spectrometry if this is a critical experiment.

What sample preparation considerations are important for detecting Polyserase-1?

Polyserase-1 is a type II transmembrane protease with active catalytic domains exposed extracellularly. Use lysis buffers containing detergent (1% Triton X-100 or NP-40) to solubilize membrane proteins efficiently. Include protease inhibitors to prevent autocatalytic degradation; Polyserase-1 has trypsin-like activity and may cleave itself or other substrates during prolonged lysis. Work quickly on ice and snap-freeze aliquots to preserve native processing patterns. Because expression is often polarized in epithelial cells, whole-cell lysates are preferable to cytosolic fractions. For surface biotinylation or co-IP experiments, verify that epitope accessibility is maintained under your capture conditions.

How should I store the Polyserase-1 antibody and how long is it stable?

Store the antibody at -20°C in single-use aliquots to avoid freeze-thaw cycles, which can reduce titer and increase aggregation. The 100 µg pack size is convenient for aliquoting 10-20 µL per tube depending on usage. Polyclonal antibodies in glycerol-containing storage buffer typically remain stable for at least two years at -20°C and up to one year at 4°C once thawed, though we recommend -20°C for long-term storage. Avoid prolonged exposure to room temperature. If you observe increased background or loss of signal over time, prepare a fresh aliquot rather than re-using a working stock repeatedly.

What positive control lysate should I use to validate Polyserase-1 antibody performance?

Select a cell line or tissue known to express TMPRSS9 at detectable levels. Published RNA-seq and proteomic databases indicate expression in differentiated epithelial cells of the gastrointestinal tract, prostate, and certain carcinoma lines. HT-29 colon adenocarcinoma or LNCaP prostate cells are reasonable starting points, though expression may be variable. If commercial control lysates are unavailable, prepare your own from confluent cultures grown under differentiation-promoting conditions. Include a TMPRSS9-negative line, such as HEK293T or NIH-3T3, as a specificity control. Comparing induced versus uninduced or siRNA-knockdown lysates provides the most rigorous validation.

Western blot validation for RP-Polyserase1 — 5 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Polyserase-1: Aminoterminal end — WB validation
WB · Panel 1 Polyserase-1: Aminoterminal end
Polyserase-1: Stem Region — WB validation
WB · Panel 2 Polyserase-1: Stem Region
Polyserase-1: Serase-1 domain — WB validation
WB · Panel 3 Polyserase-1: Serase-1 domain
Polyserase-1: Serase-2 domain — WB validation
WB · Panel 4 Polyserase-1: Serase-2 domain
Polyserase-1: Serase-3 domain — WB validation
WB · Panel 5 Polyserase-1: Serase-3 domain

Custom validation studies available on request — contact us.

Also known as:

  • TMPRSS9
  • Transmembrane protease serine 9
  • Polyserase-I
  • Polyserine protease 1
  • Serase-1
  • Serase-2
  • Serase-3
  • EC 3.4.21.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →